Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
scientific article published on 31 October 2016
Author/s
author: Roxana Mehran, George D Dangas, Stephan Windecker, Pascal Vranckx, Jan G. P. Tijssen, Gerrit-Anne van Es, Usman Baber, Karen Thomitzek, Marco Valgimigli, Peter Wildgoose, Ana Denise Zazula, Gennaro Giustino
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.